Romano Brothers And Company Danaher Corp Transaction History

Romano Brothers And Company

$757 Million
Q1 2025

A detailed history of Romano Brothers And Company transactions in Danaher Corp stock. As of the latest transaction made, Romano Brothers And Company holds 2,006 shares of DHR stock, worth $387,097. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,006

Previous 2,106 4.75%

Holding current value

$387,097

Previous $483,000 14.91%

% of portfolio

0.05%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	SELL	$201.62 - $250.59 $20,162 - $25,059	-100 Reduced 4.75%	2,006 $411,000
Q3 2024 Oct 22, 2024	SELL	$239.25 - $280.76 $11,723 - $13,757	-49 Reduced 2.27%	2,106 $585,000
Q2 2024 Jul 17, 2024	SELL	$235.51 - $267.98 $5,416 - $6,163	-23 Reduced 1.06%	2,155 $538,000
Q1 2024 Apr 17, 2024	SELL	$224.58 - $256.19 $11,678 - $13,321	-52 Reduced 2.33%	2,178 $543,000
Q4 2023 Jan 29, 2024	BUY	$185.1 - $233.13 $214,716 - $270,430	1,160 Added 108.41%	2,230 $515,000
Q3 2023 Oct 17, 2023	SELL	$233.08 - $265.59 $592,256 - $674,864	-2,541 Reduced 70.37%	1,070 $265,000
Q3 2023 Oct 17, 2023	BUY	$233.08 - $265.59 $634,210 - $722,670	2,721 Added 254.3%	3,791 $940,000
Q2 2023 Jul 12, 2023	BUY	$224.99 - $256.14 $60,297 - $68,645	268 Added 8.02%	3,611 $866,000
Q1 2023 Apr 13, 2023	BUY	$239.75 - $277.0 $25,893 - $29,916	108 Added 3.34%	3,343 $842,000
Q4 2022 Jan 17, 2023	SELL	$241.42 - $282.29 $6,276 - $7,339	-26 Reduced 0.8%	3,235 $0
Q3 2022 Oct 18, 2022	BUY	$247.06 - $1507.4 $805,662 - $4.92 Million	3,261 New	3,261 $842,000

Others Institutions Holding DHR

# of Institutions

2,542

Shares Held

536M

Call Options Held

7.24M

Put Options Held

4.28M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $140B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

News

Stay updated on Romano Brothers And Company with notifications on news.

Account

Romano Brothers And Company Danaher Corp Transaction History